ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,754Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 1019

$885K Total Retail Price of All Prescriptions

Rank: 12 out of 1019

1,152 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 13,896 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
CARVEDILOL 1,081 1,002 1 3
AMLODIPINE BESYLATE 828 780 2 4
LISINOPRIL 669 632 3 2
ISOSORBIDE MONONITRATE ER 669 649 3 12
METOPROLOL TARTRATE 604 575 5 8
CLOPIDOGREL 556 499 6 7
FUROSEMIDE 503 472 7 6
METOPROLOL SUCCINATE 501 479 8 1
ATORVASTATIN CALCIUM 453 424 9 10
PLAVIX 427 404 10 11
AMLODIPINE BESYLATE-BENAZEPRIL 409 372 11 47
DIGOXIN 402 361 12 14
SIMVASTATIN 372 352 13 5
WARFARIN SODIUM 365 354 14 9
SOTALOL 302 278 15 35
SPIRONOLACTONE 284 268 16 23
PRAVASTATIN SODIUM 280 251 17 16
HYDROCHLOROTHIAZIDE 268 261 18 18
POTASSIUM CHLORIDE 266 246 19 15
ATENOLOL 247 230 20 19
NITROSTAT 240 222 21 27
COUMADIN 225 214 22 54
AMIODARONE HCL 187 180 23 22
BENAZEPRIL HCL 186 176 24 69
CRESTOR 185 181 25 13
RAMIPRIL 175 162 26 21
DOXAZOSIN MESYLATE 161 156 27 65
DIOVAN 158 158 28 20
ZETIA 154 142 29 30
LOSARTAN POTASSIUM 139 139 30 17
CLONIDINE HCL 130 129 31 29
DIOVAN HCT 123 119 32 39
RANEXA 114 114 33 32
LANOXIN 114 114 33 167
VYTORIN 111 111 35 62
LOSARTAN-HYDROCHLOROTHIAZIDE 102 97 36 31
PANTOPRAZOLE SODIUM 102 96 36 46
TOPROL XL 96 95 38 101
LISINOPRIL-HYDROCHLOROTHIAZIDE 88 88 39 28
CILOSTAZOL 87 86 40 45
XARELTO 87 82 40 67
FENOFIBRATE 85 85 42 58
TRILIPIX 83 75 43 70
EFFIENT 82 82 44 53
NIASPAN 77 77 45 33
LIPITOR 76 76 46 37
TRICOR 61 61 47 61
PRADAXA 60 60 48 24
FLECAINIDE ACETATE 55 46 49 51
PACERONE 51 41 50 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.